EP7: CD33 AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA (AML) 

CD33 is a surface protein predominantly expressed in myeloid lineage, including those involved in Acute Myeloid Leukemia (AML). Hence, this is a great target for AML treatment. In this week's talk, we explore CD33 expressing pattern and see how this marker can be used to develop effective treatment for AML patients
Subscribe to our SCSE club: us02web.zoom.u...
💪🏻If you have any further questions or require support, contact us at: support@bioturing.com
#CD33 #AML # myeloid #therapeutictarget